Security key
221015100
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)
CUSIP: 221015100
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 91,091,040
- Total 13F shares
- 27,387,121
- Share change
- -288,551
- Total reported value
- $44,913,000
- Put/Call ratio
- 69%
- Price per share
- $1.64
- Number of holders
- 52
- Value change
- -$1,201,434
- Number of buys
- 20
- Number of sells
- 27
Report period
Q1 2022
Institutions
52
Top holders
10
CRVS full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Corvus Pharmaceuticals, Inc. SEC filings
Corvus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 221015100
Recent filing periods:
Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
7.6%
|
6,943,654
|
$16,734,000 | — | 31 Dec 2021 | |
| ADAMS STREET PARTNERS LLC |
13F
|
Company |
3.6%
|
3,275,616
|
$7,894,000 | — | 31 Dec 2021 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.4%
|
3,101,709
|
$7,475,000 | — | 31 Dec 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.2%
|
2,920,059
|
$7,037,000 | — | 31 Dec 2021 | |
| BVF INC/IL |
13F
|
Company |
1.5%
|
1,370,947
|
$3,304,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
1,231,750
|
$2,968,000 | — | 31 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
1,043,732
|
$2,515,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1%
|
930,447
|
$2,242,000 | — | 31 Dec 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.87%
|
795,000
|
$1,916,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.84%
|
763,400
|
$1,840,000 | — | 31 Dec 2021 | |
| Anson Funds Management LP |
13F
|
Company |
0.58%
|
528,358
|
$1,273,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.56%
|
507,272
|
$1,223,000 | — | 31 Dec 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.55%
|
500,000
|
$1,205,000 | — | 31 Dec 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.54%
|
492,384
|
$1,187,000 | — | 31 Dec 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.53%
|
482,610
|
$1,163,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.52%
|
475,081
|
$1,145,000 | — | 31 Dec 2021 | |
| CHI Advisors LLC |
13F
|
Company |
0.44%
|
400,000
|
$964,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
284,874
|
$686,000 | — | 31 Dec 2021 | |
| Venrock Adviser, LLC |
13F
|
Company |
0.27%
|
250,000
|
$603,000 | — | 31 Dec 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
224,300
|
$541,000 | — | 31 Dec 2021 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.21%
|
192,909
|
$465,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
105,805
|
$255,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.11%
|
100,400
|
$242,000 | — | 31 Dec 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.09%
|
81,166
|
$194,000 | — | 31 Dec 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
75,718
|
$182,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
68,080
|
$165,000 | — | 31 Dec 2021 | |
| Jump Financial, LLC |
13F
|
Company |
0.06%
|
55,500
|
$134,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
52,168
|
$126,000 | — | 31 Dec 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
48,211
|
$116,000 | — | 31 Dec 2021 | |
| CAXTON ASSOCIATES LP |
13F
|
Company |
0.05%
|
43,325
|
$104,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
36,783
|
$88,000 | — | 31 Dec 2021 | |
| LMR Partners LLP |
13F
|
Company |
0.03%
|
30,000
|
$72,000 | — | 31 Dec 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
29,397
|
$71,000 | — | 31 Dec 2021 | |
| Walleye Capital LLC |
13F
|
Company |
0.03%
|
26,582
|
$64,000 | — | 31 Dec 2021 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.03%
|
24,000
|
$58,000 | — | 31 Dec 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.03%
|
23,245
|
$56,000 | — | 31 Dec 2021 | |
| Dynamic Technology Lab Private Ltd |
13F
|
Company |
0.02%
|
20,168
|
$49,000 | — | 31 Dec 2021 | |
| Hikari Power Ltd |
13F
|
Company |
0.02%
|
19,959
|
$48,000 | — | 31 Dec 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
17,564
|
$42,000 | — | 31 Dec 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
13,118
|
$32,000 | — | 31 Dec 2021 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.01%
|
11,814
|
$28,000 | — | 31 Dec 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
11,592
|
$28,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
11,217
|
$28,000 | — | 31 Dec 2021 | |
| MERCER GLOBAL ADVISORS INC /ADV |
13F
|
Company |
0.01%
|
10,550
|
$25,000 | — | 31 Dec 2021 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
10,500
|
$25,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
9,270
|
$22,000 | — | 31 Dec 2021 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.01%
|
5,699
|
$13,000 | — | 31 Dec 2021 | |
| WHITTIER TRUST CO OF NEVADA INC |
13F
|
Company |
0%
|
4,200
|
$10,000 | — | 31 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
4,103
|
$10,000 | — | 31 Dec 2021 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
3,000
|
$7,000 | — | 31 Dec 2021 |
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q1 2022
As of 31 Mar 2022,
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,387,121 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, TANG CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, CHI Advisors LLC, BVF INC/IL, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Point72 Asset Management, L.P., and Ikarian Capital, LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
58
Q1 2022 holders
52
Holder diff
-6
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.